Pardes Biosciences to Host Virtual Investor Event
Company to host conference call and webcast at 3 p.m. PT on Tuesday, February 15, 2022CARLSBAD, Calif., Feb. 09, 2022...
News
Atea Pharmaceuticals to Present at 11th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the...
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
• FDA Agreed to PolyPid Request for the Addition of an Unblinded Interim Analysis in SHIELD I once 750 Patients...
BioXcel Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
NEW HAVEN, Conn., Feb. 09, 2022 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial...
Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...
Psyence Group Announces DTC Eligibility Approval in the U.S.
TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...
IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials for the Treatment and Prevention of COVID-19
– In vitro studies indicate IGM-6268 exhibits potent neutralization activity against the Omicron variant and all other Variants of Concern and Variants...
Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference
SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or...
ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer
ANN ARBOR, Mich., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for...
SweetWater Brewing Company Expands Distribution Across California
11th Largest Craft Brewer in the U.S., SweetWater, Launches Partnership with the Country’s Largest Beer Distributor, Reyes Beer Division West...
HOOKIPA to Present at the SVB Leerink Global Healthcare Conference
NEW YORK and VIENNA, Austria, Feb. 09, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing...
Medicenna Reports Third Quarter Fiscal 2022 Financial Results and Operational Highlights
-- Phase 1/2 ABILITY study of MDNA11 on track with first set of efficacy results from early dose escalation cohorts...
Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 First Quarter Financial Results
Company to host a webcast today at 4:30 p.m. Eastern Time NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences...
TCR² Therapeutics to Present at the SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a...
Veru Reports First Quarter Fiscal 2022 Results as US FC2 Prescription Net Revenues Climb 27%
--FC2 Prescription Business Entering 6th Year of Growth -- --FDA Approves Company’s ENTADFI™, New Treatment for Benign Prostatic Hyperplasia with...
The New Delta 9 THC Gummies Launched By Exhale Wellness
LOS ANGELES, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Exhale Wellness has launched a hemp product with a legal amount of...
Opthea Announces Presentation at the Angiogenesis, Exudation, and Degeneration 2022 Conference
MELBOURNE, Australia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies...
Tranquility Online’s Internet-Based Cognitive Behavioural Therapy Platform Validated in Journal of Medical Internet Research Publication
Halifax, Nova Scotia--(Newsfile Corp. - February 9, 2022) - Tranquility Online (Tranquility) received clinical validation in an evaluation study authored...
Bloom Health Partners Provides Guidance and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2022) - Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom"...
LevelJump Closes Second Round of $177,500 of $2.5 Million Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - February 9, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...